D-0857-2020 Class II Terminated

Recalled by Contract Pharmacal Corporation — Hauppauge, NY

FDA drug recall D-0857-2020 was initiated by Contract Pharmacal Corporation on Feb 3, 2020 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle. The recall status is terminated (terminated Apr 22, 2024). Affected quantity: 5472 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Feb 3, 2020
Termination Date
Apr 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5472 bottles

Product description

Leader Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer,100-count bottles,Distributed by Cardinal Health, Dublin OHIO 43017 NDC 7000-0036-1, UPC 0 96295 13807 8

Reason for recall

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 193005, Exp. Date 08/21

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0857-2020
openFDA file date
Nov 17, 2026
Loaded by RegDataLab
Nov 18, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0857-2020. Report a data issue: hello@regdatalab.com.